Global Healthcare IT Spending – Market Analysis 2015-2019

2015-09-23
Price :
Published : Sep-2015
No. of Pages : 104

Healthcare enterprises worldwide have become increasingly dependent on technology and various IT products, solutions, and services to run their business and drive revenue growth. Healthcare IT systems improve the quality and efficiency of the services delivered in the healthcare industry. IT in healthcare is essential to develop a secure environment for patient data storage and maintain a uniform flow of information. These services help reinvent organizations by facilitating the development of more cost-effective structures and centralization of their processes. Both the private and public sector’s healthcare organizations are engaging in projects that depend heavily on IT. Private companies in particular are spending more on IT, and this trend is expected to continue during the forecast period. The need to maintain standard record formats and financial incentives from governments and other international welfare organizations also encourage investment in IT in the healthcare industry.

The analysts forecast global healthcare IT spending market to grow at a CAGR of 6.44% over the period 2014-2019.

Covered in this report

This report covers the current scenario and the growth prospects of the global healthcare IT spending market for the period of 2015-2019. To calculate the market size, This report considers the revenue generated from the healthcare segments, which include:

  • Hardware
  • Software
  • Services
  • Telecommunications

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

This report also provides a brief overview of various technologies in Healthcare IT:

  • Cloud computing
  • Big Data
  • Data analytics
  • Mobile

The report, Global Healthcare IT Spending Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. This report also covers the landscape of the market and its growth prospects in the coming years. This report includes a discussion of the key vendors operating in this market.

Key vendors

  • BD
  • Cerner
  • Dell
  • GE Healthcare
  • InterSystems
  • McKesson
  • Philips Healthcare
  • Siemens Healthcare

Other prominent vendors

  • 21st Century Informatics
  • 3M
  • Adcock Ingram
  • Agfa Healthcare
  • Agility Global Health Solutions
  • Allscripts Healthcare Solutions
  • Athenahealth
  • Bytes Healthcare Solutions
  • Carestream Health
  • Epic systems
  • Gijima Group
  • Honeywell
  • HP
  • IBM
  • Intel
  • Medical Information Technology
  • Mediware Information System
  • NextGen Healthcare Information systems
  • Novarad
  • Omnicell
  • Oracle
  • Roche Group
  • Sekunjalo Healthcare
  • TIBCO software
  • Trifour Healthcare
  • T-Systems Enterprise Services

Market driver

  • Increased adoption of clinical information systems
  • For a full, detailed list, view our report

Market challenge

  • Increased security concerns
  • For a full, detailed list, view our report

Market trend

  • Increased need for remote monitoring
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

EpiCast Report: Alzheimer’s Disease – Epidemiology Forecast to 2026

EpiCast Report: Alzheimer's Disease - Epidemiology Forecast to 2026 Summary Alzheimer's disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, characterized by the death of brain cells, which leads to a progressive decline in memory and cognitive abilities, such as thinking, language, and learning capacity (NIA, 2017). AD is the most common cause of dementia in people age 60 years and older, and accounts for approximately 75% of the total dementia cases worldwide. To forecast the total prevalent cases of AD in adults ages 60 years and older in the 7MM during the forecast period (2016-2026), our epidemiologists identified country-specific population-based studies that used the diagnostic criteria based on the Diagnostic and Sta......
$3995

EpiCast Report: Epilepsy – Epidemiology Forecast to 2026

EpiCast Report: Epilepsy - Epidemiology Forecast to 2026 Summary Epilepsy is a brain disorder characterized by recurrent and unpredictable seizures that are caused by sudden, disorderly, and excessive neuronal activity in the brain (WHO, 2017). It is one of the most common neurological conditions globally (WHO, 2017). Epilepsy can start at any age and can be a life-long condition. It is diagnosed after a patient has suffered a seizure and is referred to a specialist, where a description of the symptoms before the seizure and the seizure itself are used for a diagnosis (NHS, 2014). In the 7MM, the lifetime diagnosed prevalent cases of epilepsy will increase from almost 11 million cases in 2016 to just over 11.5 million cases in 2026, at an Annual Growth Rate (AGR) of almost 0.5% pe......
$3995

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report p......
$1000

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Argentina

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Argentina Summary Pharmaceutical market increased from over US$3 Billion in 2009 to around US$6.5 Billion in 2016, at a Compound Annual Growth Rate (CAGR) of nearly 10%. It is expected to cross US$10 Billion in 2021 at a CAGR of about 10%. In 2009, the medical device market was valued at just over US$1 Billion. It grew at a CAGR of 4% between 2009 and 2016 and reached around US$1.3 Billion. It is expected to grow at a CAGR of about 5%, from around US$1.4 Billion in 2017 to over US$1.7 Billion in 2021. Argentina is the third-largest pharmaceutical market in Latin America after Brazil and Mexico. With a relatively low-cost base and high-quality professionals in the biotechnology sector, Argentina is home to over 130 ......
$1995

EpiCast Report: Melanoma – Epidemiology Forecast to 2026

EpiCast Report: Melanoma - Epidemiology Forecast to 2026 Summary Melanoma is a malignant neoplasm of melanocytes, the pigment cells in the skin located on the epidermis, the most superficial layer of skin (WHO, 2014). Melanocytes are embryological derivatives of neural crest tissue, and as such, any region of the body that is a derivative of the neural crest and contains melanocytes-namely areas of skin, meninges, mucous membranes, esophagus, and eyes-can develop melanoma (Komarnicky-Kocher and Alite, 2013). In the 7MM, our epidemiologists forecast the diagnosed incident cases of melanoma to increase to over 200,000 cases by 2026, at an Annual Growth Rate (AGR) of almost 2.5%. The US will have the highest number of melanoma cases throughout the forecast period. The five-year diagn......
$3995

EpiCast Report: Crohn’s Disease – Epidemiology Forecast to 2026

EpiCast Report: Crohn's Disease - Epidemiology Forecast to 2026 Summary Crohn's disease (CD) is an inflammatory bowel disease (IBD) characterized by chronic inflammation of the gastrointestinal tract. While any part of the gastrointestinal tract can be affected, inflammation is most commonly found at the end of the small intestine (ileum), and the start of the large intestine (colon). The disease course of CD is characterized by periods of remission followed by periods of relapse, the length and severity of which differ from case to case (CDC, 2014; NHS, 2015). Inflammation in CD can result in severe scarring and narrowing of the parts of the bowel. Our epidemiologists forecast that the diagnosed incident cases of CD in the 7MM will increase from 70,985 in 2016 to 74,712 in 2026 a......
$3995

Hypercholesterolemia Global Clinical Trials Review, H2, 2017

Hypercholesterolemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hypercholesterolemia Global Clinical Trials Review, H2, 2017" provides an overview of Hypercholesterolemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercholesterolemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Cl......
$2500

Hyperemia Global Clinical Trials Review, H2, 2017

Hyperemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are ......
$2500

Hypereosinophilic Syndrome Global Clinical Trials Review, H2, 2017

Hypereosinophilic Syndrome Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hypereosinophilic Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Hypereosinophilic Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Hypereosinophilic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary dat......
$2500

Hyperglycemia Global Clinical Trials Review, H2, 2017

Hyperglycemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperglycemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperglycemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500